NCT06445725

Brief Summary

The goal of this pilot clinical trial is to learn about the feasibility and acceptability of promotores (community health workers) delivering an educational intervention for Hispanic/Latino patients with type 2 diabetes. The main questions it aims to answer are:

  • Participate in four research visits: provide fingerstick blood samples before and after the program (at 6 months), and complete questionnaires at four times times during the program (before, twice during, and at 6 months).
  • Participate in the ABaCo program: join seven (7) individual phone call visits with promotores to review educational information about caring for diabetes while keeping connected to life values. Each phone call lasts approximately 45 minutes once per week for six (6) weeks, then a refresher visit is a month later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable type-2-diabetes

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 24, 2025

Completed
Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

1.1 years

First QC Date

April 18, 2024

Last Update Submit

August 20, 2025

Conditions

Keywords

community health workeracceptance and commitment therapytask shiftingaccess to care

Outcome Measures

Primary Outcomes (2)

  • Average blood glucose management (HbA1c)

    Glycated hemoglobin (HbA1c) is the average blood glucose levels in past 3 months (HbA1c); higher percentages reflect higher levels of blood glucose (worse blood glucose management).

    0, 24 weeks

  • Quality of life: Patient Reported Outcomes Measurement Information System Global-10

    PROMIS-10 consists of 10 items that assess physical and mental health, functioning, emotional distress, interference, overall quality of life. There are two subscales - Global Physical Health and Global Mental Health. The raw score range for both subscales is 4 to 20, but raw scores are converted to T-scores with a range of 20-80. Higher scores indicate better health. Strong psychometrics.

    0, 6, 10, 24 weeks

Secondary Outcomes (5)

  • Diabetes Acceptance: Acceptance & Action Diabetes Questionnaire (AADQ)

    0, 6, 10, 24 weeks

  • Diabetes Acceptance: Diabetes Acceptance Scale (DAS)

    0, 6, 10, 24 weeks

  • Self-management: Summary of Diabetes Self-Care Activities

    0, 6, 10, 24 weeks

  • Diabetes Distress: Diabetes Distress Scale

    0, 6, 10, 24 weeks

  • Emotional Distress: Patient Health Questionnaire-4

    0, 6, 10, 24 weeks

Other Outcomes (4)

  • Feasibility: Recruitment

    24 weeks

  • Feasibility: Retention

    24 weeks

  • Acceptability: Interviews

    10 weeks

  • +1 more other outcomes

Study Arms (1)

Acceptance Based Coping (ABaCo) Skills Training

EXPERIMENTAL

Participant-patients will receive care as usual in the Nosotros Promotores program at University Health Robert B Green Campus Family Health Center, including standardized procedures (e.g., home visits, phone calls and in-clinic visits), along with this protocol - individual telephone-delivered ABaCo skills intervention delivered by one Promotor/a for 10 weeks (6 weeks plus booster at 10 weeks).

Behavioral: Acceptance Based Coping (ABaCo)

Interventions

The educational ABaCo protocol consists of core Acceptance \& Commitment Therapy (ACT) interventions, culturally and contextually-tailored for this population, and in accordance with clinician-led versions of ACT for diabetes to include (a) identification of patient values, (b) teaching acceptance and brief mindfulness skills, and (c) techniques for engaging in valued activities while coping with difficult experiences (e.g., sugar cravings, distress). It is delivered by a community health worker (promotor/a) over 6 consecutive weeks over the phone, followed by a booster call at week 10.

Acceptance Based Coping (ABaCo) Skills Training

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-70
  • Diagnosis of Type 2 Diabetes (T2DM)
  • HbA1c of 7.5% or greater (may be taking oral agents or injectables for T2DM management)
  • Evidence of avoidance coping (prescreen of \<48.4 on English or a \<52 on the Spanish Acceptance and Action Diabetes Questionnaire) and/or poor self-management skills (prescreen below recommended frequencies in 2 or more sub-scales of the Summary of Diabetes Self-Care Activities)
  • Self-identifies as Hispanic/Latino
  • Receiving ongoing care at study site clinic
  • Preferred language is English or Spanish

You may not qualify if:

  • A medical condition or life circumstance that would contraindicate participation
  • Inability to read/comprehend the informed consent process or study instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229, United States

Location

Related Publications (5)

  • Gregg JA, Callaghan GM, Hayes SC, Glenn-Lawson JL. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol. 2007 Apr;75(2):336-43. doi: 10.1037/0022-006X.75.2.336.

    PMID: 17469891BACKGROUND
  • Schmitt A, Reimer A, Kulzer B, Icks A, Paust R, Roelver KM, Kaltheuner M, Ehrmann D, Krichbaum M, Haak T, Hermanns N. Measurement of psychological adjustment to diabetes with the diabetes acceptance scale. J Diabetes Complications. 2018 Apr;32(4):384-392. doi: 10.1016/j.jdiacomp.2018.01.005. Epub 2018 Jan 31.

    PMID: 29439862BACKGROUND
  • Barnett ML, Lau AS, Miranda J. Lay Health Worker Involvement in Evidence-Based Treatment Delivery: A Conceptual Model to Address Disparities in Care. Annu Rev Clin Psychol. 2018 May 7;14:185-208. doi: 10.1146/annurev-clinpsy-050817-084825. Epub 2018 Jan 31.

    PMID: 29401043BACKGROUND
  • Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001.

    PMID: 32175717BACKGROUND
  • American Diabetes Association. Standards of Medical Care in Diabetes-2018 Abridged for Primary Care Providers. Clin Diabetes. 2018 Jan;36(1):14-37. doi: 10.2337/cd17-0119. No abstract available.

    PMID: 29382975BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Kathryn Kanzler, PsyD ABPP

    Baylor College of Medicine; UT Health San Antonio

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: single arm, pre-post, mixed-methods pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 18, 2024

First Posted

June 6, 2024

Study Start

March 4, 2024

Primary Completion

March 24, 2025

Study Completion

March 24, 2025

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Based on ethical considerations, the following data produced during the project will be preserved and shared: deidentified standardized survey data; clinical data (i.e., lab values); recruitment and retention counts; qualitative data (aggregated matrix of interview responses). To facilitate the interpretation of the data, metadata, including protocols and public data collection instruments, will be available and associated with the relevant datasets.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will be available after the publication of primary outcomes
Access Criteria
Email request to PI (Dr. Kanzler, kathryn.kanzler@bcm.edu) , who will share in accordance with institutional policies.

Locations